The world leading lateral flow device assembly solution provides manufacturers flexible production capacity within a desktop footprint.
The LFDA-3 is built on Ginolis´modular Xanthia robotic platform. The modular design provides speed, accuracy and precision, as well as flexibility for the future.
The solution is easily adaptable and can assemble different rapid tests with minimal product specific adjustments. Machine vision guidance throughout the entire system ensures a consistent high quality assembled device.
“The LFDA revolutionizes the rapid test manufacturing market. One system can assemble multiple rapid test devices with little or no changeover time” states Jorma Venäläinen, VP of Sales and Marketing at Ginolis Ltd.
“Vision guided component placement, strip cutting and assembly throughout the process ensures fast production times with high quality results.”
The revolutionary new desktop solution comes equipped with machine vision guidance, real time quality control, bulk feeders, proprietary Ginger software and a host of additional features. The LFDA-3 is available with single card, card magazine or reel infeed.
The desktop solution has an extremely quick changeover time and production capabilities up to 30 units/minute. The LFDA-3 allows you to realize all the benefits of automating your manufacturing process in a footprint that is less than three square meters.
The company is showcasing the LFDA-3 for the first time at Medica trade fair in Düsseldorf, Germany on November 14 – 17, 2016.
Ginolis is a global systems supplier that specializes in developing and providing intelligent automation and high precision liquid handling solutions for the diagnostic and MedTech industries. The company is privately owned and headquartered in Oulu, Finland, with offices in Uppsala, Sweden, San Diego, USA and Suzhou, China.
